As per a recent report in The Lancet, the incidence of prostate cancer is expected to double in India over the next few years. A crucial weapon in averting a severe health catastrophe will...

Rakesh Singh took on the tincture syndicate in Agra during his tenure as excise inspector between 2019-23; image credit: N Sundaresha Subramanian Synopsis A well-oiled syndicate of producers, wholesalers and retailers operating across several...

Offer Exclusively For You Save up to Rs. 700/- ON ET PRIME MEMBERSHIP Avail Offer Offer Exclusively For You Get 1 Year Free With 1 and 2-Year ET prime membership Avail Offer Offer Exclusively...

Illustration by Sadhana Saxena via AI. Synopsis Advent, which merged Suven Pharma with Cohance Lifesciences in February, looks to take advantage of the China+1 wave and other geopolitical tailwinds. While the skills of its...

Synopsis With an alarming rise in cancer diagnosis rate in India, especially among the younger cohort, timely screening and therapeutic intervention are the need of the hour. One small state has devised a unique...

An overlooked mental health challenge faced by new mothers. A powerful new drug could be critical in fighting back. It should have been an obvious match. Yet things may not turn out that way...

Getty Images Synopsis The new government notice tries to prevent the pharmaceutical companies from inducing doctors to prescribe their medicines through vacations, gifts, and free educational material. It is unlikely to succeed. No free...

Ranjit Shahani, former chief of Novartis Synopsis Ranjit Shahani will be remembered for his astute leadership and trademark calmness amid chaos. As chief of Novartis in India for nearly two decades, his tenure coincided...

Officials from enforcement agencies with the accused charged with making and supplying spurious drugs; image credit: Telangana Drug Control Administration Synopsis In a rare breakthrough, the Telangana drug administration has unearthed a well-oiled network...

Chris Boerner, Global CEO, Bristol Myers Squibb; image credit: BMS Synopsis “We are building to be one of the fastest-growing companies by the end of the decade,” says Chris Boerner, CEO, Bristol Myers Squibb....